The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at Commissioner Marty Makary’s request to put it off until after the midterm elections,

Two state lawmakers are sparring over how to enshrine protections in state law for women who have miscarriages or other pregnancy complications

The ballot measure also includes a ban on gender affirming health care for minors. Judges reissued the summary statement that voters will see on November 2026 ballots to make clear rights were being repealed,